Cancer Center studies a Role of Diet on the Microbiome of the Digestive System
Photo by Louis Hansel
M.D. Anderson Cancer Center is recruiting patients for the clinical trial of Role of Diet on the Microbiome of the Digestive System.
This study is to learn more about how diet affects the microbiome (bacteria and microorganisms) of the digestive system. Researchers want to learn if this, in turn, has an effect on if and how people then develop colorectal cancer.
The primary objectives are:
- To evaluate the differences in dietary patterns among individuals reporting to be vegetarian and omnivorous.
- To compare the difference in stool microbiome pattern in the above mentioned two groups of individuals.
- To compare somatic mutations in colorectal epithelial cells in the above mentioned two groups of individuals.
September 29, 2020 is the study start date. The indicative completion of the clinical trial will be expected in January 1, 2021.
The study will take place at the M D Anderson Cancer Center, Houston, Texas, United States.
There are a number of conditions that do not allow participation, such as:
- Current smokers (nicotine abuse only)
- Positive family history of colon cancer or colon cancer related syndromes
- Recent use of antibiotics in 1 month
- History of inflammatory bowel disease, and/or radiation enteritis or colitis
- Pregnant and breastfeeding women
- Heavy drinker (defined as more than 14 drinks per week)
and others.
The page dedicated to this clinical trial can be found here: https://ichgcp.net/clinical-trials-registry/NCT04666727
